BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12361820)

  • 1. Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: comparison between oral and transdermal administration of estrogen.
    Modena MG; Bursi F; Fantini G; Cagnacci A; Carbonieri A; Fortuna A; Rossi R
    Am J Med; 2002 Sep; 113(4):331-4. PubMed ID: 12361820
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
    Yilmazer M; Fenkci V; Fenkci S; Sonmezer M; Aktepe O; Altindis M; Kurtay G
    Maturitas; 2003 Dec; 46(4):245-53. PubMed ID: 14625121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS breast pain ancillary study.
    Files JA; Miller VM; Cha SS; Pruthi S
    J Womens Health (Larchmt); 2014 Oct; 23(10):801-5. PubMed ID: 25268853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F; Terek MC; Karadadaş N; Bilgin O
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.
    Shufelt CL; Merz CN; Prentice RL; Pettinger MB; Rossouw JE; Aroda VR; Kaunitz AM; Lakshminarayan K; Martin LW; Phillips LS; Manson JE
    Menopause; 2014 Mar; 21(3):260-6. PubMed ID: 24045672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy.
    Tuomikoski P; Mikkola TS; Tikkanen MJ; Ylikorkala O
    Climacteric; 2010 Oct; 13(5):457-66. PubMed ID: 20443719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.
    Edlefsen KL; Jackson RD; Prentice RL; Janssen I; Rajkovic A; O'Sullivan MJ; Anderson G
    Menopause; 2010; 17(3):622-9. PubMed ID: 20215977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
    Kaunitz AM;
    Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
    [No Abstract]   [Full Text] [Related]  

  • 12. Postmenopausal hormone replacement therapy in the light of the women's health initiative trial.
    van der Mooren MJ; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 2003 Apr; 107(2):123-4. PubMed ID: 12648855
    [No Abstract]   [Full Text] [Related]  

  • 13. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Kurabayashi M
    Atherosclerosis; 2006 Dec; 189(2):436-42. PubMed ID: 16469323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women.
    Lindheim SR; Duffy DM; Kojima T; Vijod MA; Stanczyk FZ; Lobo RA
    Fertil Steril; 1994 Dec; 62(6):1176-80. PubMed ID: 7957980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal estradiol and lipid profile: effects on a specific group of Brazilian postmenopausal women.
    Callejon DR; Rios DR; Franceschini SA; Toloi MR
    Arq Bras Cardiol; 2009 Dec; 93(6):571-5, 617-22. PubMed ID: 20379635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous estradiol/oral micronized progesterone has less-adverse effects and different gene regulations than oral conjugated equine estrogens/medroxyprogesterone acetate in the breasts of healthy women in vivo.
    Murkes D; Lalitkumar PG; Leifland K; Lundström E; Söderqvist G
    Gynecol Endocrinol; 2012 Oct; 28 Suppl 2():12-5. PubMed ID: 22834417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women.
    Wakatsuki A; Okatani Y; Fukaya T
    Circulation; 2002 Dec; 106(24):e198-9; author reply e198-9. PubMed ID: 12473568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.